Pfizer & ACG, AGA & C&C  Provide $1+ Million to IBD Research

Mar 16, 2019 | Crohn's Disease, Irritable Bowel Disease (IBD)

Healio reports The American Gastroenterological Association, American College of Gastroenterology and Crohn’s & Colitis Foundation have partnered with Pfizer to offer more than $1 million for research to promote health maintenance and address vaccine use in patients with inflammatory bowel disease.  A key stakeholder is Francis A. Farraye, MD, MMSc, FACG, AGAF, director of the Inflammatory Bowell Disease Center at Boston Medical Center and chair of the steering committee for the partnership between ACG, AGA and the Crohn’s & Colitis Foundation.

0 Comments

Pin It on Pinterest